Drug
Tasipimidine
Tasipimidine: highest development phase Phase 2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tasipimidine NCT06956495 | Phase 2 | Insomnia |
Latest
No recent events.
Follow Tasipimidine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.